SOFMARKI
Status timeline
- 15 Apr 2026Application filedNew Application Entered
- 22 Jun 2026Assigned to an examining attorneyAssigned To Examiner
- 22 Jun 2026Approved for publicationApproved For Pub - Principal Register
- 21 Jul 2026Published for oppositionPublished For Opposition
All 8 USPTO events
| 2026-07-21 | Published For Opposition |
| 2026-07-21 | Official Gazette Publication Confirmation E-Mailed |
| 2026-07-15 | Notification Of Notice Of Publication E-Mailed |
| 2026-06-22 | Assigned To Examiner |
| 2026-06-22 | Approved For Pub - Principal Register |
| 2026-04-15 | New Application Entered |
| 2026-04-15 | Application Filing Receipt Mailed |
| 2026-04-15 | New Application Office Supplied Data Entered |
Goods & services
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, m…
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 21 Jul 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.